94 related articles for article (PubMed ID: 7037592)
1. Structural relationship between human high and low molecular mass urokinase.
Günzler WA; Steffens GJ; Otting F; Buse G; Flohé L
Hoppe Seylers Z Physiol Chem; 1982 Feb; 363(2):133-41. PubMed ID: 7037592
[TBL] [Abstract][Full Text] [Related]
2. The complete amino acid sequence of low molecular mass urokinase from human urine.
Steffens GJ; Günzler WA; Otting F; Frankus E; Flohé L
Hoppe Seylers Z Physiol Chem; 1982 Sep; 363(9):1043-58. PubMed ID: 6754572
[TBL] [Abstract][Full Text] [Related]
3. Human low-molecular-weight urinary urokinase. Partial characterization and preliminary sequence data of the two polypeptide chains.
Schaller J; Nick H; Rickli EE; Gillessen D; Lergier W; Studer RO
Eur J Biochem; 1982 Jul; 125(2):251-7. PubMed ID: 6749491
[TBL] [Abstract][Full Text] [Related]
4. Primary structure of single-chain pro-urokinase.
Kasai S; Arimura H; Nishida M; Suyama T
J Biol Chem; 1985 Oct; 260(22):12382-9. PubMed ID: 2931434
[TBL] [Abstract][Full Text] [Related]
5. The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain.
Günzler WA; Steffens GJ; Otting F; Kim SM; Frankus E; Flohé L
Hoppe Seylers Z Physiol Chem; 1982 Oct; 363(10):1155-65. PubMed ID: 6754569
[TBL] [Abstract][Full Text] [Related]
6. International collaborative study on the assay of commerically available high and low molecular weight urokinases.
Gaffney PJ; Tydeman MS; Kirkwood TB; Aronson D; Murano G
Thromb Haemost; 1981 Feb; 45(1):34-7. PubMed ID: 7018003
[TBL] [Abstract][Full Text] [Related]
7. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
Robbins KC; Tanaka Y
Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
[TBL] [Abstract][Full Text] [Related]
8. Subunit structure of deglycosylated human and swine trachea and Cowper's gland mucin glycoproteins.
Sangadala S; Kim D; Brewer JM; Mendicino J
Mol Cell Biochem; 1991 Mar; 102(1):71-93. PubMed ID: 2052001
[TBL] [Abstract][Full Text] [Related]
9. Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type-2 and urokinases.
Kiso U; Kaudewitz H; Henschen A; Astedt B; Kruithof EK; Bachmann F
FEBS Lett; 1988 Mar; 230(1-2):51-6. PubMed ID: 3280346
[TBL] [Abstract][Full Text] [Related]
10. Adaptation of plasminogen activator sequences to known protease structures.
Strassburger W; Wollmer A; Pitts JE; Glover ID; Tickle IJ; Blundell TL; Steffens GJ; Günzler WA; Otting F; Flohé L
FEBS Lett; 1983 Jul; 157(2):219-23. PubMed ID: 6345197
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence polarization assay of plasmin, plasminogen, and plasminogen activator.
Kinoshita K; Maeda H; Hinuma Y
Anal Biochem; 1980 May; 104(1):15-22. PubMed ID: 6446247
[No Abstract] [Full Text] [Related]
12. Localization of the cleavage sites on fibronectin following digestion by urokinase.
Gold LI; Rostagno A; Frangione B; Passalaris T
J Cell Biochem; 1992 Dec; 50(4):441-52. PubMed ID: 1469074
[TBL] [Abstract][Full Text] [Related]
13. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
Nakamura S; Iwanaga S; Suzuki T
J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
[TBL] [Abstract][Full Text] [Related]
14. The light-harvesting polypeptides of Rhodopseudomonas sphaeroides R-26.1. I. Isolation, purification and sequence analyses.
Theiler R; Suter F; Wiemken V; Zuber H
Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):703-19. PubMed ID: 6384009
[TBL] [Abstract][Full Text] [Related]
15. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.
Goretzki L; Schmitt M; Mann K; Calvete J; Chucholowski N; Kramer M; Günzler WA; Jänicke F; Graeff H
FEBS Lett; 1992 Feb; 297(1-2):112-8. PubMed ID: 1551416
[TBL] [Abstract][Full Text] [Related]
16. Solid-phase enzyme immunoassay of urokinase using monoclonal antibodies.
Hérion P; Portetelle D; Franssen JD; Urbain J; Bollen A
Biosci Rep; 1983 Apr; 3(4):381-8. PubMed ID: 6347271
[TBL] [Abstract][Full Text] [Related]
17. Urinary and kidney cell plasminogen activator (urokinase).
Barlow GH
Methods Enzymol; 1976; 45():239-44. PubMed ID: 1011995
[No Abstract] [Full Text] [Related]
18. Characterization of radioimmunoassays for high- and low-molecular weight urokinases and estimation of different molecular forms of urokinase in urine and plasma.
Cheung T; Lui AY; Lau HK
J Lab Clin Med; 1993 Mar; 121(3):461-71. PubMed ID: 8445294
[TBL] [Abstract][Full Text] [Related]
19. The activation mechanism of human plasminogen.
Rickli EE
Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
[No Abstract] [Full Text] [Related]
20. Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G.
Beaufort N; Leduc D; Rousselle JC; Magdolen V; Luther T; Namane A; Chignard M; Pidard D
J Immunol; 2004 Jan; 172(1):540-9. PubMed ID: 14688365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
